Ex-Steelers QB Batch creates sports medicine startup at Pitt
Steelers quarterback Charlie Batch takes questions from media after arriving at Monessen High School on Sept. 4, 2012.
Photo by Brian F. Henry | Trib Total Media
Former Steelers quarterback Charlie Batch is among a group of partners who have created a new sports medicine partnership at the University of Pittsburgh.
Impellia will develop fitness, human performance and rehabilitation products with the goal of commercialization, according to a press release from Pitt. The company has optioned three products created by the Pitt Innovation Institute, including a telemedicine product, a knee function product and a joint-function product. All three are nearly ready for commercialization.
“Sports medicine and rehabilitation technology is a natural draw for me. What we see in these technologies is the ability for us to bring innovation available to elite athletes out to everyday people,” said Batch, a Steelers backup from 2003-12.
One product, interACTION, uses sensors placed on joints which collect data on the movement of the joint. The data are transmitted to a tablet, where a physical therapist can analyze the performance of the joint.
Another product, called Versatile and Integrated System for Telerehabilitation, is an app for videoconferencing and accessing health records.
The third is called PIVOT, and also involves sensors transmitting real-time data on the health of a major joint, the knee. The product allows doctors to better diagnose tears in the anterior cruciate ligament.
The Pittsburgh Technology Council facilitated the partnership.
TribLive commenting policy
You are solely responsible for your comments and by using TribLive.com you agree to our Terms of Service.
We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.
While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.
We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments â either by the same reader or different readers.
We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.
We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.
We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.
We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.